ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

AQST Aquestive Therapeutics Inc

3.28
-0.085 (-2.53%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Aquestive Therapeutics Inc AQST NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.085 -2.53% 3.28 09:00:00
始値 安値 高値 終値 前日終値
3.40 3.205 3.4099 3.28 3.365
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2920:00GLOBEAquestive Therapeutics Receives U.S. FDA Approval and Market..
2024/4/2521:00GLOBEAquestive Therapeutics to Report First Quarter 2024..
2024/4/1305:01GLOBEAquestive Therapeutics to Present Crossover Study Data for..
2024/4/0121:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
2024/3/2521:00GLOBEAquestive Therapeutics Announces Closing of Underwritten..
2024/3/2010:49GLOBEAquestive Therapeutics Announces Pricing of $75 Million..
2024/3/2005:01GLOBEAquestive Therapeutics Announces Proposed Public Offering of..
2024/3/1506:23GLOBEAquestive Therapeutics Announces Pivotal Study for Anaphylm™..
2024/3/1123:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1123:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1123:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1123:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1123:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1123:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1123:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:14EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0607:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0607:09EDGAR2Form 8-K - Current report
2024/3/0607:05GLOBEAquestive Therapeutics Reports Full Year 2023 Financial..
2024/2/2122:00GLOBEAquestive Therapeutics to Report Fourth Quarter 2023..
2024/2/1522:00GLOBEAquestive Therapeutics to Present Anaphylm™ (epinephrine)..
2024/2/1505:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1307:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/3022:00GLOBEAquestive Therapeutics to Participate in Oppenheimer 34th..
2023/12/0900:46EDGAR2Form 8-K - Current report
2023/12/0522:51EDGAR2Form 8-K - Current report
2023/12/0522:00GLOBEAquestive Therapeutics Doses First Patient in Phase 3..
2023/11/1022:00GLOBEAquestive Therapeutics to Present Positive Data from..
2023/11/0907:04EDGAR2Form 8-K - Current report
2023/11/0707:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0707:20EDGAR2Form 8-K - Current report
2023/11/0706:37GLOBEAquestive Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0221:45EDGAR2Form 8-K - Current report
2023/11/0221:00GLOBEAquestive Therapeutics Completes $45 Million Debt..
2023/10/3121:00GLOBEAquestive Therapeutics to Report Third Quarter 2023..
2023/10/1101:04EDGAR2Form 8-K - Current report
2023/10/0921:00GLOBEAquestive Therapeutics Provides Business Update
2023/10/0305:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/0213:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/2105:39EDGAR2Form 8-K - Current report
2023/9/2023:57DJNAquestive Therapeutics Shares Rise 12% on Anaphylm Trial..
2023/9/2022:04GLOBEAquestive Therapeutics Reaffirms Timeline and Pathway for..
2023/9/1121:00GLOBEAquestive Therapeutics Receives FDA Acceptance of New Drug..
2023/8/2321:00GLOBEAquestive Therapeutics to Participate in Two Upcoming..
2023/8/1202:14EDGAR2Form 8-K - Current report
2023/8/1006:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/1005:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock